BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10881992)

  • 1. Epstein-Barr virus-infected B-chronic lymphocyte leukemia cells express the virally encoded nuclear proteins but they do not enter the cell cycle.
    Teramoto N; Gogolák P; Nagy N; Maeda A; Kvarnung K; Björkholm T; Klein E
    J Hum Virol; 2000; 3(3):125-36. PubMed ID: 10881992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-barr virus can infect B-chronic lymphocytic leukemia cells but it does not orchestrate the cell cycle regulatory proteins.
    Maeda A; Bandobashi K; Nagy N; Teramoto N; Gogolák P; Pokrovskaja K; Székely L; Björkholm M; Klein G; Klein E
    J Hum Virol; 2001; 4(5):227-37. PubMed ID: 11907380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
    Park CH; Kim HR; Kim J; Jang SH; Lee KY; Chung GH; Jang YS
    J Cell Biochem; 2004 Mar; 91(4):777-85. PubMed ID: 14991769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40.
    Crawford DH; Thomas JA; Gregory CD; Catovsky D; Chaggar K
    Leukemia; 1995 May; 9(5):747-53. PubMed ID: 7539512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection of leukaemic B lymphocytes by Epstein Barr virus.
    Doyle MG; Catovsky D; Crawford DH
    Leukemia; 1993 Nov; 7(11):1858-64. PubMed ID: 8231253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes.
    Klein G; Klein E; Kashuba E
    Biochem Biophys Res Commun; 2010 May; 396(1):67-73. PubMed ID: 20494113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes.
    Zimber-Strobl U; Strobl LJ
    Semin Cancer Biol; 2001 Dec; 11(6):423-34. PubMed ID: 11669604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
    Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
    J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resting B-cells, EBV-infected B-blasts and established lymphoblastoid cell lines differ in their Rb, p53 and EBNA-5 expression patterns.
    Szekely L; Pokrovskaja K; Jiang WQ; Selivanova G; Löwbeer M; Ringertz N; Wiman KG; Klein G
    Oncogene; 1995 May; 10(9):1869-74. PubMed ID: 7753563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of the lytic LMP-1 protein in EBV-infected B-cells suggests its presence in the virion.
    Erickson KD; Martin JM
    Virology; 1997 Jul; 234(1):1-13. PubMed ID: 9234942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus (EBV) can immortalize B-cll cells activated by cytokines.
    Wendel-Hansen V; Sällström J; De Campos-Lima PO; Kjellström G; Sandlund A; Siegbahn A; Carlsson M; Nilsson K; Rosén A
    Leukemia; 1994 Mar; 8(3):476-84. PubMed ID: 8127151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear receptors and their role in Epstein -- Barr virus induced B cell transformation.
    Yenamandra SP; Klein G; Kashuba E
    Exp Oncol; 2009 Jun; 31(2):67-73. PubMed ID: 19550394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.
    Kis LL; Takahara M; Nagy N; Klein G; Klein E
    Immunol Lett; 2006 Apr; 104(1-2):83-8. PubMed ID: 16386314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to fludarabine-induced apoptosis in Epstein-Barr virus infected B cells.
    Fagard R; Mouas H; Dusanter-Fourt I; Devillers C; Bissières P; Martin A; Lenoir G; VanTan H; Feuillard J; Raphaël M
    Oncogene; 2002 Jul; 21(29):4473-80. PubMed ID: 12085225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular pathological characteristics of human B-cell lymphomas induced by Epstein-Barr virus].
    Gan RL; Yin ZH; Liu TF; Dong BH; Zhou JG; Yao KT
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):925-9. PubMed ID: 14515211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
    Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
    Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immortalized Epstein-Barr virus-positive B-cell lines obtained by prolonged culture of peripheral blood mononuclear cells from human immunodeficiency virus type 1-positive patients.
    Ruibal-Ares B; Belmonte L; Baré P; Scolnik M; Palacios MF; Bayo-Hanza C; Galmarini CM; Mendez G; de Bracco MM
    J Hum Virol; 2001; 4(4):200-13. PubMed ID: 11694848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
    Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
    J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.